tiprankstipranks
Trending News
More News >
Sanofi (SNY)
NASDAQ:SNY
US Market
Advertisement

Sanofi (SNY) Ratios

Compare
2,038 Followers

Sanofi Ratios

SNY's free cash flow for Q1 2025 was €0.73. For the 2025 fiscal year, SNY's free cash flow was decreased by € and operating cash flow was €0.22. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.37 1.27 1.42 1.44 1.75
Quick Ratio
0.69 0.87 1.05 1.03 1.32
Cash Ratio
0.25 0.36 0.53 0.47 0.72
Solvency Ratio
0.14 0.18 0.23 0.18 0.30
Operating Cash Flow Ratio
0.11 0.42 0.44 0.49 0.39
Short-Term Operating Cash Flow Coverage
0.48 4.42 2.36 3.05 2.48
Net Current Asset Value
€ -13.46B€ -21.46B€ -17.54B€ -20.65B€ -17.46B
Leverage Ratios
Debt-to-Assets Ratio
0.16 0.15 0.17 0.19 0.21
Debt-to-Equity Ratio
0.28 0.25 0.28 0.33 0.38
Debt-to-Capital Ratio
0.22 0.20 0.22 0.25 0.27
Long-Term Debt-to-Capital Ratio
0.14 0.16 0.17 0.20 0.24
Financial Leverage Ratio
1.78 1.71 1.69 1.75 1.81
Debt Service Coverage Ratio
1.07 3.04 2.45 2.55 4.63
Interest Coverage Ratio
13.25 7.20 36.43 22.08 20.72
Debt to Market Cap
0.19 0.15 0.34 0.37 0.46
Interest Debt Per Share
17.55 15.59 17.31 18.19 19.20
Net Debt to EBITDA
1.29 0.81 0.60 1.09 0.56
Profitability Margins
Gross Profit Margin
71.13%69.07%69.83%68.72%67.47%
EBIT Margin
18.55%17.86%24.32%20.83%38.11%
EBITDA Margin
23.05%26.06%30.98%28.82%46.87%
Operating Profit Margin
18.55%17.11%37.00%20.74%21.63%
Pretax Profit Margin
17.21%15.54%23.11%19.91%36.94%
Net Profit Margin
14.39%11.73%18.44%15.89%32.90%
Continuous Operations Profit Margin
14.00%11.81%18.69%16.03%33.00%
Net Income Per EBT
83.62%75.49%79.80%79.80%89.06%
EBT Per EBIT
92.76%90.83%62.46%95.96%170.80%
Return on Assets (ROA)
4.78%4.27%6.61%5.18%10.75%
Return on Equity (ROE)
8.48%7.29%11.19%9.06%19.48%
Return on Capital Employed (ROCE)
8.15%7.70%16.34%8.21%8.49%
Return on Invested Capital (ROIC)
6.04%5.84%12.67%6.35%7.15%
Return on Tangible Assets
9.25%10.24%15.17%12.26%23.78%
Earnings Yield
6.11%4.81%14.78%11.28%24.67%
Efficiency Ratios
Receivables Turnover
97.93 4.17 4.22 4.00 3.75
Payables Turnover
0.58 1.94 2.01 1.98 2.30
Inventory Turnover
0.58 1.47 1.53 1.41 1.46
Fixed Asset Turnover
3.86 3.90 3.88 3.27 3.54
Asset Turnover
0.33 0.36 0.36 0.33 0.33
Working Capital Turnover Ratio
3.47 5.57 4.70 3.30 3.29
Cash Conversion Cycle
10.49 147.48 143.65 166.69 189.00
Days of Sales Outstanding
3.73 87.54 86.41 91.19 97.22
Days of Inventory Outstanding
631.15 247.83 238.85 259.57 250.76
Days of Payables Outstanding
624.39 187.88 181.62 184.06 158.98
Operating Cycle
634.88 335.37 325.27 350.75 347.97
Cash Flow Ratios
Operating Cash Flow Per Share
2.85 8.20 8.41 8.40 5.94
Free Cash Flow Per Share
1.29 5.87 6.65 6.77 4.26
CapEx Per Share
1.53 2.42 1.76 1.63 1.69
Free Cash Flow to Operating Cash Flow
0.45 0.72 0.79 0.81 0.72
Dividend Paid and CapEx Coverage Ratio
0.53 1.37 1.65 1.74 1.23
Capital Expenditure Coverage Ratio
1.86 3.39 4.78 5.15 3.52
Operating Cash Flow Coverage Ratio
0.17 0.56 0.50 0.47 0.31
Operating Cash Flow to Sales Ratio
0.08 0.22 0.23 0.27 0.20
Free Cash Flow Yield
1.56%6.54%14.70%15.37%10.70%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
16.36 20.81 6.76 8.87 4.05
Price-to-Sales (P/S) Ratio
2.32 2.44 1.25 1.41 1.33
Price-to-Book (P/B) Ratio
1.39 1.52 0.76 0.80 0.79
Price-to-Free Cash Flow (P/FCF) Ratio
64.05 15.28 6.80 6.51 9.34
Price-to-Operating Cash Flow Ratio
29.32 10.95 5.38 5.24 6.69
Price-to-Earnings Growth (PEG) Ratio
1.23 -1.05 0.20 -0.18 0.01
Price-to-Fair Value
1.39 1.52 0.76 0.80 0.79
Enterprise Value Multiple
11.38 10.17 4.63 5.98 3.40
Enterprise Value
114.83B 122.06B 65.10B 67.50B 59.60B
EV to EBITDA
11.38 10.17 4.63 5.98 3.40
EV to Sales
2.62 2.65 1.43 1.72 1.59
EV to Free Cash Flow
72.26 16.60 7.82 7.96 11.17
EV to Operating Cash Flow
32.66 11.90 6.18 6.41 8.00
Tangible Book Value Per Share
60.31 0.50 2.89 -0.34 0.44
Shareholders’ Equity Per Share
60.03 59.15 59.74 54.84 50.34
Tax and Other Ratios
Effective Tax Rate
0.20 0.22 0.19 0.20 0.13
Revenue Per Share
35.48 36.78 36.26 31.28 29.81
Net Income Per Share
5.10 4.31 6.69 4.97 9.81
Tax Burden
0.84 0.75 0.80 0.80 0.89
Interest Burden
0.93 0.87 0.95 0.96 0.97
Research & Development to Revenue
0.17 0.15 0.15 0.15 0.15
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 0.00 <0.01 <0.01 <0.01
Income Quality
0.76 1.90 1.26 1.69 0.60
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis